Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Muehlenbein, CE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Value in Health 2010 13(3):A28-A28
Autor:
Gruschkus, SK, Hoverman, JR, Muehlenbein, CE, Forsyth, M, Chen, C, Lopez, W, Lawson, AH, Pohl, G
Publikováno v:
In Value in Health 2010 13(3):A24-A24
Publikováno v:
In Value in Health 2009 12(3):A39-A39
Publikováno v:
In Value in Health 2009 12(3):A14-A14
Autor:
Stokes, ME, Muehlenbein, CE, Marciniak, MD, Faries, D, Motabar, S, Buesching, DP, Gillespie, TW, Lipscomb, J, Knopf, KB
Publikováno v:
In Value in Health 2008 11(3):A10-A10
Autor:
Winfree, KB1 (AUTHOR), Zhang, KH2 (AUTHOR), Muehlenbein, CE1 (AUTHOR), Panjic, EH1 (AUTHOR), Ale-Ali, A.1 (AUTHOR), Graham, CN2 (AUTHOR)
Publikováno v:
Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS143-S143. 1p.
Autor:
Peloquin S; AXDEV Group Inc, Brossard, QC, Canada. peloquins@axdevgroup.com., Cymbalista F; Université Sorbonne Paris Nord, Bobigny, France., Dreyling M; Ludwig-Maximilian-University Hospital Munich, Munich, Germany., Shah NN; Medical College of Wisconsin, Milwaukee, WI, USA., Murray S; AXDEV Group Inc, Brossard, QC, Canada., Del Fiacco R; Eli Lilly and Company, Florence, Toscana, Italy., Muehlenbein CE; Eli Lilly and Company, Indianapolis, IN, USA., Lazure P; AXDEV Group Inc, Brossard, QC, Canada.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Aug 13; Vol. 24 (1), pp. 1003. Date of Electronic Publication: 2024 Aug 13.
Autor:
Roeker LE; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Coombs CC; Department of Medicine, University of California Irvine Health, Orange, California, USA., Shah NN; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Washington, Australia., Patel K; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, Washington, USA., Maddocks K; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Wang Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Munir T; Department of Haematology, St. James's University Hospital, Leeds, UK., Koh Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Thompson MC; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Muehlenbein CE; Loxo@Lilly, Indianapolis, Indiana, USA., Wang C; Eli Lilly and Company, Indianapolis, Indiana, USA., Sizelove R; Eli Lilly and Company, Indianapolis, Indiana, USA., Abhyankar S; Eli Lilly and Company, Indianapolis, Indiana, USA., Hasanabba S; Eli Lilly and Company, Indianapolis, Indiana, USA., Tsai DE; Loxo@Lilly, Indianapolis, Indiana, USA., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, UK., Wang M; MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Acta haematologica [Acta Haematol] 2024 Jun 05, pp. 1-17. Date of Electronic Publication: 2024 Jun 05.
Autor:
Garon EB; David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Santa Monica, CA 90404, USA. Electronic address: egaron@mednet.ucla.edu., Aerts J; Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, Netherlands. Electronic address: j.aerts@erasmusmc.nl., Kim JS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: kim_jong_seok@lilly.com., Muehlenbein CE; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: muehlenbein_catherine_e@lilly.com., Peterson P; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: Peterson_patrick@lilly.com., Rizzo MT; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: rizzo_maria_teresa@lilly.com., Gadgeel SM; Henry Ford Cancer Institute/Henry Ford Health System, 2799 W Grand Blvd K13, Detroit, MI 48202, USA. Electronic address: sgadgee1@hfhs.org.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Sep; Vol. 183, pp. 107285. Date of Electronic Publication: 2023 Jul 15.